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Abstract
© 2018  by  the  authors  The  tetracyclic  pyrido[4,3-b]carbazole  olivacine  and  four  of  its
oxygenated derivatives have been synthesized by a late-stage palladium-catalyzed Heck-type
cyclization of  the pyrrole ring as a key step.  In a test  for  the inhibition of  the growth of
Mycobacterium tuberculosis, 9-methoxyolivacine showed the most significant inhibitory activity
against Mycobacterium tuberculosis, with an MIC90 value of 1.5 µM.
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